Cargando…

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent

COVID-19, which was first reported in December 2019 in China, has caused a global outbreak. Five variants of concern (VOCs) have been identified in different countries since the global pandemic, namely, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.529). Although m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Gong, Yixin, Jiao, Shunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041375/
https://www.ncbi.nlm.nih.gov/pubmed/35492429
http://dx.doi.org/10.2217/fvl-2021-0100
_version_ 1784694533209980928
author Zhang, Meng
Gong, Yixin
Jiao, Shunchang
author_facet Zhang, Meng
Gong, Yixin
Jiao, Shunchang
author_sort Zhang, Meng
collection PubMed
description COVID-19, which was first reported in December 2019 in China, has caused a global outbreak. Five variants of concern (VOCs) have been identified in different countries since the global pandemic, namely, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.529). Although multiple vaccines have been found to be effective, some of the amino acid changes may increase the infectivity of virus and decrease the sensitivity to antibodies. Here we characterize the VOCs and discuss their sensitivity to antibodies elicited by convalescent and vaccinee sera. In conclusion, several variants display a reduction in the susceptibility to neutralization antibodies generated by natural infection or vaccination, which threatens the containment of the epidemic.
format Online
Article
Text
id pubmed-9041375
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-90413752022-04-27 Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent Zhang, Meng Gong, Yixin Jiao, Shunchang Future Virol Review COVID-19, which was first reported in December 2019 in China, has caused a global outbreak. Five variants of concern (VOCs) have been identified in different countries since the global pandemic, namely, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.529). Although multiple vaccines have been found to be effective, some of the amino acid changes may increase the infectivity of virus and decrease the sensitivity to antibodies. Here we characterize the VOCs and discuss their sensitivity to antibodies elicited by convalescent and vaccinee sera. In conclusion, several variants display a reduction in the susceptibility to neutralization antibodies generated by natural infection or vaccination, which threatens the containment of the epidemic. Future Medicine Ltd 2022-04-26 2022-03 /pmc/articles/PMC9041375/ /pubmed/35492429 http://dx.doi.org/10.2217/fvl-2021-0100 Text en © 2022 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Review
Zhang, Meng
Gong, Yixin
Jiao, Shunchang
Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
title Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
title_full Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
title_fullStr Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
title_full_unstemmed Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
title_short Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
title_sort neutralization heterogeneity of circulating sars-cov-2 variants to sera elicited by a vaccinee or convalescent
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041375/
https://www.ncbi.nlm.nih.gov/pubmed/35492429
http://dx.doi.org/10.2217/fvl-2021-0100
work_keys_str_mv AT zhangmeng neutralizationheterogeneityofcirculatingsarscov2variantstoseraelicitedbyavaccineeorconvalescent
AT gongyixin neutralizationheterogeneityofcirculatingsarscov2variantstoseraelicitedbyavaccineeorconvalescent
AT jiaoshunchang neutralizationheterogeneityofcirculatingsarscov2variantstoseraelicitedbyavaccineeorconvalescent